BACKGROUND: Trehalose, a nonreducing disaccharide of glucose, is synthesized as a stress response factor when cells are exposed to stressful conditions. In the cornea, oxidative stress plays the key role in the development of acute corneal inflammatory response to UVB rays, photokeratitis. We found previously that trehalose reduced UVB-induced oxidative effects on the formation of cytotoxic peroxynitrite, apoptotic corneal epithelial cell death and changes in corneal optics. The aim of the present study was to examine whether trehalose might inhibit UVB-mediated proinflammatory cytokine and matrix metalloproteinase induction and the development of an antioxidant/pro-oxidant imbalance in the corneal epithelium, changes found previously to be strongly involved in the acute corneal UVB-induced inflammation. The expression of heat shock protein 70 as a potential biomarker for corneal UVB-induced damage was also examined. METHODS: The corneas of New Zealand white rabbits were irradiated with UVB rays, 312 nm, daily dose of 0.5 J/cm(2) for 4 days. During the irradiation, trehalose drops were applied on the right eye and buffered saline on the left eye. One day after the end of irradiations, the animals were killed and the corneas examined immunohistochemically for the expression of antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase), pro-oxidant xanthine oxidoreductase/xanthine oxidase, proinflammatory cytokines (interleukin-6, interleukin-8), matrix metalloproteinase-9 and heat shock protein 70. RESULTS: After buffered saline treatment during UVB irradiation, an antioxidant/pro-oxidant imbalance appeared in the corneal epithelium: The expression of antioxidant enzymes was highly reduced, whereas the expression of pro-oxidant xanthine oxidase was increased. The pronounced expression of pro-inflammatory cytokines, matrix metalloproteinase and heat shock protein 70 was found in the UVB-irradiated corneal epithelium. Trehalose application significantly suppressed all the above-mentioned UVB-induced corneal disturbances. CONCLUSIONS: Trehalose favorably influenced the oxidative damage of the cornea caused by UVB rays. Trehalose suppressed proinflammatory cytokine induction. It is suggested that suppression of proinflammatory cytokines contributed strongly to reduced matrix metalloproteinase and xanthine oxidase expression in the UVB-irradiated corneal epithelium and to the decreased development of an antioxidant/pro-oxidant imbalance. The overexpression of heat shock protein 70 found in UVB-irradiated cornea after buffered saline treatment was reduced after trehalose application.

Laboratory of Eye Histochemistry and Pharmacology Institute of Experimental Medicine Academy of Sciences of Czech Republic Vídenská 1083 14220 Prague 4 Czech Republic

Zobrazit více v PubMed

J Korean Med Sci. 2004 Aug;19(4):591-7 PubMed

Histol Histopathol. 2010 Nov;25(11):1403-16 PubMed

Exp Eye Res. 2000 Feb;70(2):221-6 PubMed

Photochem Photobiol. 2007 May-Jun;83(3):652-7 PubMed

J Mol Med (Berl). 2005 May;83(5):343-52 PubMed

Histol Histopathol. 2001 Apr;16(2):523-33 PubMed

Shock. 2007 Jan;27(1):91-6 PubMed

Int Ophthalmol. 1990 Oct;14(5-6):345-7 PubMed

Histol Histopathol. 2000 Oct;15(4):1043-50 PubMed

J Biol Chem. 1997 May 2;272(18):12144-50 PubMed

Physiol Res. 2004;53(1):1-10 PubMed

J Biol Chem. 2001 Jun 29;276(26):24261-7 PubMed

Histol Histopathol. 2005 Apr;20(2):467-73 PubMed

Exp Dermatol. 2001 Jun;10(3):155-60 PubMed

Biochim Biophys Acta. 1998 Jul 23;1381(2):191-202 PubMed

Curr Probl Dermatol. 2001;29:83-94 PubMed

FASEB J. 1991 May;5(8):2145-54 PubMed

Glycobiology. 2003 Apr;13(4):17R-27R PubMed

Toxicology. 2009 Jan 8;255(1-2):1-5 PubMed

Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3430-7 PubMed

Vet Ophthalmol. 2008 May-Jun;11(3):135-44 PubMed

Biochem Soc Trans. 1997 Aug;25(3):783-6 PubMed

Toxicology. 2003 Mar 3;184(2-3):141-7 PubMed

Ophthalmic Res. 2006;38(2):105-14 PubMed

Photochem Photobiol. 1993 Apr;57(4):663-6 PubMed

Oncogene. 2004 Apr 12;23(16):2907-18 PubMed

Mol Vis. 2009;15:577-83 PubMed

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1552-8 PubMed

Exp Eye Res. 2009 Sep;89(3):311-8 PubMed

J Biol Chem. 2010 Feb 19;285(8):5848-58 PubMed

Am J Med. 1991 Sep 30;91(3C):14S-22S PubMed

Pulm Pharmacol Ther. 2005;18(4):297-302 PubMed

Exp Eye Res. 2004 May;78(5):1007-14 PubMed

Ann Ophthalmol. 1979 May;11(5):765-9 PubMed

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2165-8 PubMed

Free Radic Biol Med. 2003 May 1;34(9):1178-89 PubMed

Cornea. 2000 Jan;19(1):99-103 PubMed

Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1680-7 PubMed

Am J Pathol. 1997 Oct;151(4):1105-13 PubMed

Biochem Biophys Res Commun. 2008 Sep 12;374(1):44-8 PubMed

Am J Pathol. 1992 Dec;141(6):1279-84 PubMed

Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2483-91 PubMed

J Clin Invest. 1995 Mar;95(3):926-33 PubMed

J Dermatol Sci. 2009 Sep;55(3):161-9 PubMed

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):776-81 PubMed

Protein Sci. 2009 Jan;18(1):24-36 PubMed

Carcinogenesis. 2007 Mar;28(3):537-44 PubMed

The Healing of Oxidative Injuries with Trehalose in UVB-Irradiated Rabbit Corneas

Clinically Relevant Solution for the Hypothermic Storage and Transportation of Human Multipotent Mesenchymal Stromal Cells

Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries